Literature DB >> 11291626

Origins and clinical relevance of sarcopenia.

R Roubenoff1.   

Abstract

Sarcopenia is the loss of muscle mass and strength that occurs with normal aging. Because sarcopenia is not the result of a disease, it is seen in all aged adults. Sarcopenia markedly increases the risk of disability and loss of functional capacity in the elderly. The mechanisms underlying sarcopenia are complex and are reviewed here. It is not clear at this time which factors are most important in determining the severity or rate of development of sarcopenia. While progressive resistance training clearly can reverse and prevent sarcopenia, little is known about the mechanisms by which aged muscle adapts to training, or whether these adaptations reflect reversal of direct pathophysiological processes or compensation by activation of separate pathways from those leading to the deterioration in the first place. As populations in developed countries continue to age, diagnosing, treating, and preventing sarcopenia will be progressively more important to the health and well-being of modern societies.

Entities:  

Mesh:

Year:  2001        PMID: 11291626     DOI: 10.1139/h01-006

Source DB:  PubMed          Journal:  Can J Appl Physiol        ISSN: 1066-7814


  39 in total

1.  Effects of 17-day spaceflight on electrically evoked torque and cross-sectional area of the human triceps surae.

Authors:  Marco Narici; Bengt Kayser; Paolo Barattini; Paolo Cerretelli
Journal:  Eur J Appl Physiol       Date:  2003-09-17       Impact factor: 3.078

2.  The effect of age and tongue exercise on BDNF and TrkB in the hypoglossal nucleus of rats.

Authors:  Allison J Schaser; Kyle Stang; Nadine P Connor; Mary Behan
Journal:  Behav Brain Res       Date:  2011-09-21       Impact factor: 3.332

3.  Impact of lifelong sedentary behavior on mitochondrial function of mice skeletal muscle.

Authors:  Pedro A Figueiredo; Scott K Powers; Rita M Ferreira; Francisco Amado; Hans J Appell; José A Duarte
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-05-22       Impact factor: 6.053

Review 4.  Pathogenesis and Management of Sarcopenia.

Authors:  Robinder J S Dhillon; Sarfaraz Hasni
Journal:  Clin Geriatr Med       Date:  2017-02       Impact factor: 3.076

5.  Aging of the immune system causes reductions in muscle stem cell populations, promotes their shift to a fibrogenic phenotype, and modulates sarcopenia.

Authors:  Ying Wang; Michelle Wehling-Henricks; Steven S Welc; Allison L Fisher; Qun Zuo; James G Tidball
Journal:  FASEB J       Date:  2018-08-21       Impact factor: 5.191

Review 6.  Clinical definition of sarcopenia.

Authors:  Valter Santilli; Andrea Bernetti; Massimiliano Mangone; Marco Paoloni
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

7.  Effects of aging on the lateral transmission of force in rat skeletal muscle.

Authors:  Chi Zhang; Yingxin Gao
Journal:  J Biomech       Date:  2014-01-20       Impact factor: 2.712

8.  Glial cell line-derived neurotrophic factor (GDNF) expression and NMJ plasticity in skeletal muscle following endurance exercise.

Authors:  A M Gyorkos; M J McCullough; J M Spitsbergen
Journal:  Neuroscience       Date:  2013-11-08       Impact factor: 3.590

9.  Mortality as an adverse outcome of sarcopenia.

Authors:  V E Arango-Lopera; P Arroyo; L M Gutiérrez-Robledo; M U Pérez-Zepeda; M Cesari
Journal:  J Nutr Health Aging       Date:  2013-03       Impact factor: 4.075

Review 10.  Forum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR workshop.

Authors:  Lynda F Bonewald; Douglas P Kiel; Thomas L Clemens; Karyn Esser; Eric S Orwoll; Regis J O'Keefe; Roger A Fielding
Journal:  J Bone Miner Res       Date:  2013-09       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.